Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.

× No keyword cloud information.

18 in total

1. Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes.

Authors: M L Bajenaru; J Donahoe; T Corral; K M Reilly; S Brophy; A Pellicer; D H Gutmann
Journal: Glia Date: 2001-03-15 Impact factor: 7.452

2. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.

Authors: M E Zöller; B Rembeck; A Odén; M Samuelsson; L Angervall
Journal: Cancer Date: 1997-06-01 Impact factor: 6.860

Review 3. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors: M Miettinen; J Lasota
Journal: Virchows Arch Date: 2001-01 Impact factor: 4.064

4. Neurofibromatosis with gastrointestinal stromal tumors: insights into the association.

Authors: Shih-Ping Cheng; Ming-Jer Huang; Tsen-Long Yang; Chin-Yuan Tzen; Chien-Liang Liu; Tsang-Pai Liu; Shu-Ching Hsiao
Journal: Dig Dis Sci Date: 2004-08 Impact factor: 3.199

Review 5. Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease).

Authors: C E Fuller; G T Williams
Journal: Histopathology Date: 1991-07 Impact factor: 5.087

Review 6. Biology of gastrointestinal stromal tumors.

Authors: Christopher L Corless; Jonathan A Fletcher; Michael C Heinrich
Journal: J Clin Oncol Date: 2004-09-15 Impact factor: 44.544

7. Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.

Authors: David A Ingram; Mary Jo Wenning; Kevin Shannon; D Wade Clapp
Journal: Blood Date: 2002-10-17 Impact factor: 22.113

8. PDGFRA activating mutations in gastrointestinal stromal tumors.

Authors: Michael C Heinrich; Christopher L Corless; Anette Duensing; Laura McGreevey; Chang-Jie Chen; Nora Joseph; Samuel Singer; Diana J Griffith; Andrea Haley; Ajia Town; George D Demetri; Christopher D M Fletcher; Jonathan A Fletcher
Journal: Science Date: 2003-01-09 Impact factor: 47.728

9. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Authors: Michael C Heinrich; Christopher L Corless; George D Demetri; Charles D Blanke; Margaret von Mehren; Heikki Joensuu; Laura S McGreevey; Chang-Jie Chen; Annick D Van den Abbeele; Brian J Druker; Beate Kiese; Burton Eisenberg; Peter J Roberts; Samuel Singer; Christopher D M Fletcher; Sandra Silberman; Sasa Dimitrijevic; Jonathan A Fletcher
Journal: J Clin Oncol Date: 2003-12-01 Impact factor: 44.544

10. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.

Authors: D A Ingram; F C Yang; J B Travers; M J Wenning; K Hiatt; S New; A Hood; K Shannon; D A Williams; D W Clapp
Journal: J Exp Med Date: 2000-01-03 Impact factor: 14.307

15 in total

1. Gastrointestinal bleeding and cutaneous nodules.

Authors: Alka Mittal; Daniel Felter; S Michelle Shiller; A David McCollum; Jeffrey P Lamont; Damien Mallat
Journal: Proc (Bayl Univ Med Cent) Date: 2008-07

Review 2. The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations.

Authors: Sosipatros A Boikos; Constantine A Stratakis
Journal: Endocrine Date: 2014-07-16 Impact factor: 3.633

Review 3. Neoplasms associated with germline and somatic NF1 gene mutations.

Authors: Sachin Patil; Ronald S Chamberlain
Journal: Oncologist Date: 2012-01-12

4. Gastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1.

Authors: Hwan Namgung
Journal: J Korean Surg Soc Date: 2011-10-28

Review 5. Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases.

Authors: Daniel Relles; Jennie Baek; Agnieszka Witkiewicz; Charles J Yeo
Journal: J Gastrointest Surg Date: 2010-03-19 Impact factor: 3.452

6. Rare c-KIT c.1926delA and c.1936T>G Mutations in Exon 13 Define Imatinib Resistance in Gastrointestinal Stromal Tumors and Melanoma Patients: Case Reports and Cell Experiments.

Authors: Chi Yan; Chengzhi Zhao; Ke Yang; Hongyan Zhou; Limin Jing; Weixing Zhao; Wenguang Dou; Qingxin Xia; Jie Ma; Bing Wei; Yongjun Guo
Journal: Front Mol Biosci Date: 2022-06-02

Review 7. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations.

Authors: Abbas Agaimy; Nikolaos Vassos; Roland S Croner
Journal: Int J Clin Exp Pathol Date: 2012-10-20

8. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q.

Authors: Hidetaka Yamamoto; Taro Tobo; Mari Nakamori; Masakazu Imamura; Aya Kojima; Yoshinao Oda; Norimoto Nakamura; Tomonari Takahira; Takashi Yao; Masazumi Tsuneyoshi
Journal: J Cancer Res Clin Oncol Date: 2008-11-20 Impact factor: 4.553

9. Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists.

Authors: Jeanny H Wang; Jerzy Lasota; Markku Miettinen
Journal: J Cancer Date: 2011-02-16 Impact factor: 4.207

Review 10. Gastrointestinal stromal tumors associated with neurofibromatosis 1: a single centre experience and systematic review of the literature including 252 cases.

Authors: Pier Federico Salvi; Laura Lorenzon; Salvatore Caterino; Laura Antolino; Maria Serena Antonelli; Genoveffa Balducci
Journal: Int J Surg Oncol Date: 2013-12-09